Volume 23, Issue 1 (Iranian South Medical Journal 2020)
Iran South Med J 2020, 23(1): 36-47 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mostafavi A, Hashemi H, Tabatabaei S A. Maternal and Fetal Outcomes in Pregnant Women with Cardiac Diseases Presenting to Shariati Hospital Cardiovascular Department from 21st March 2017 to 20th March 2018. Iran South Med J 2020; 23 (1) :36-47
URL: http://ismj.bpums.ac.ir/article-1-1241-en.html
URL: http://ismj.bpums.ac.ir/article-1-1241-en.html
1- Department of Cardiovascular Diseases, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
2- Department of Cardiovascular Diseases, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran ,tabatabaeiseyedah@gmail.com
2- Department of Cardiovascular Diseases, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran ,
Abstract: (3971 Views)
Background: Cardiac diseases are considered as major cause of maternal mortality during pregnancy and account for about 10% of all maternal mortalities. Cardiac diseases cause complications for both mother and fetus. In this study, we evaluated the effects of cardiac diseases on pregnancy and vice versa. Three groups of complications were examined: complication of maternal heart (serious and life-threatening or not
life-threatening), complications during laber and complications of infant/fetus.
Materials and Methods: This is a descriptive cross-sectional study on pregnant women with heart diseases. Maternal age at pregnancy, type of heart disease, maternal paraclinical information, pregnancy termination, maternal adverse outcomes, infants’ first- and fifth-minute apgar score, and neonatal outcomes and abortions were recorded. After collecting these data, statistical analysis was performed using SPSS20 software.
Results: Mothers with tetralogy of fallot (P=0.000), coronary artery disease (P=0.045), aortic coarctation (P=0.000), and eclampsia or pre-eclampsia (P=0.000) experienced a significantly worse condition. However, infants of mothers with chronic hypertension needed NICU significantly less as compared with those with other heart diseases (P<0.001). Maternal death was not reported in our study, and there was a significant deterioration in mothers with valvular diseases (P=0.005) and coronary artery disease (P=0.022). The need for admission to the ICU was significantly lower in mothers with chronic hypertension as compared to those with other illnesses (P=<0.001).
Conclusion: In our study, mothers with cardiovascular diseases, tetralogy of fallot, coronary artery disease, history of pre-eclampsia, history of aortic coarctation, valvular diseases, and dilated cardiomyopathy had more complications in neonates. Among the valvular diseases, mitral valve disease was also associated with a worse condition in neonates.
life-threatening), complications during laber and complications of infant/fetus.
Materials and Methods: This is a descriptive cross-sectional study on pregnant women with heart diseases. Maternal age at pregnancy, type of heart disease, maternal paraclinical information, pregnancy termination, maternal adverse outcomes, infants’ first- and fifth-minute apgar score, and neonatal outcomes and abortions were recorded. After collecting these data, statistical analysis was performed using SPSS20 software.
Results: Mothers with tetralogy of fallot (P=0.000), coronary artery disease (P=0.045), aortic coarctation (P=0.000), and eclampsia or pre-eclampsia (P=0.000) experienced a significantly worse condition. However, infants of mothers with chronic hypertension needed NICU significantly less as compared with those with other heart diseases (P<0.001). Maternal death was not reported in our study, and there was a significant deterioration in mothers with valvular diseases (P=0.005) and coronary artery disease (P=0.022). The need for admission to the ICU was significantly lower in mothers with chronic hypertension as compared to those with other illnesses (P=<0.001).
Conclusion: In our study, mothers with cardiovascular diseases, tetralogy of fallot, coronary artery disease, history of pre-eclampsia, history of aortic coarctation, valvular diseases, and dilated cardiomyopathy had more complications in neonates. Among the valvular diseases, mitral valve disease was also associated with a worse condition in neonates.
Type of Study: Original |
Subject:
Cardiovascular System
Received: 2019/07/1 | Accepted: 2019/12/10 | Published: 2020/03/28
Received: 2019/07/1 | Accepted: 2019/12/10 | Published: 2020/03/28
References
1. Montoya ME, Karnath BM, Ahmad M. Endocarditis During Pregnancy. South Med J 2003; 96(11): 1156-7. [DOI:10.1097/01.SMJ.0000054503.18393.1E]
2. McClure JH, Cooper GM, Clutton-Brock TH, et al. Saving Mothers' Lives: Reviewing Maternal Deaths to Make Motherhood Safer: 2006-8: A Review. Br J Anaesth 2011; 107(2): 127-32. [DOI:10.1093/bja/aer192]
3. Siu SC, Sermer M, Colman JM, et al. Prospective Multicenter Study of Pregnancy Outcomes in Women with Heart Disease. Circulation 2001; 104(5): 515-21. [DOI:10.1161/hc3001.093437]
4. Dadegar A, Pourjavad M. Seven Years Study of Pregnant Woman with Cardiovascular Disease Departement of Cardiology, Imam Reza Hospital Mashhad IRAN ,(1996-2003). Iran J Obstet Gynecol 2005; 7(2): 84-90. (Persian) [Link]
5. Ashrafi R, Curtis SL. Heart Disease and Pregnancy. Cardiol Ther 2017; 6(2): 157-73. [DOI:10.1007/s40119-017-0096-4]
6. Abbasi S, Siddiqua SF, Rijvi S, et al. Study of Maternal and Fetal Outcome in Pregnancy with Heart Disease. Anwer Khan Mod Med Coll J 2017; 8(2): 112-6. [DOI:10.3329/akmmcj.v8i2.33666]
7. Lust KM, Boots RJ, Dooris M, et al. Management of Labor in Eisenmenger Syndrome with Inhaled Nitric Oxide. Am J Obstet Gynecol 1999; 181(2): 419-23. [DOI:10.1016/S0002-9378(99)70572-7]
8. Siu SC, Colman JM. Heart Disease and Pregnancy. Heart 2001; 85(6): 710-5. [DOI:10.1136/heart.85.6.710]
9. Foeller ME, Foeller TM, Druzin M. Maternal Congenital Heart Disease in Pregnancy. Obstet Gynecol Clin North Am 2018; 45(2): 267-80. [DOI:10.1016/j.ogc.2018.01.011]
10. Koutrolou-Sotiropoulou P, Parikh PB, Miller C, et al. Impact of Heart Disease on Maternal and Fetal Outcomes in Pregnant Women. Am J Cardiol 2015; 116(3): 474-80. [DOI:10.1016/j.amjcard.2015.04.063]
11. Owens A, Yang J, Nie L, et al. Neonatal and Maternal Outcomes in Pregnant Women With Cardiac Disease. J Am Heart Assoc 2018; 7(21): e009395. [DOI:10.1161/JAHA.118.009395]
12. Gelson E, Curry R, Gatzoulis MA, et al. Effect of Maternal Heart Disease on Fetal Growth. Obstet Gynecol 2011; 117(4): 886-91. [DOI:10.1097/AOG.0b013e31820cab69]
13. Campanharo FF, Cecatti JG, Haddad SM, et al. The Impact of Cardiac Diseases during Pregnancy on Severe Maternal Morbidity and Mortality in Brazil. PLoS One 2015; 10(12): e0144385. [DOI:10.1371/journal.pone.0144385]
14. Aka N, Arpaciota S, Vural F, et al. Perinatal and Neonatal Outcomes of Maternal Heart Diseases. Clin Exp Obstet Gynecol 2016; 43(4): 560-4. [PubMed]
15. Asghar F, Kokab H. Evaluation and Outcome of Pregnancy Complicated by Heart Disease. J Pak Med Assoc 2005; 55(10): 416-9. [PubMed]
16. Ng AT, Duan L, Win T, et al. Maternal and Fetal Outcomes in Pregnant Women with Heart Failure. Heart 2018; 104(23): 1949-54. [DOI:10.1136/heartjnl-2018-313156]
17. Hameed A, Karaalp IS, Tummala PP, et al. The Effect of Valvular Heart Disease on Maternal and Fetal Outcome of Pregnancy. J Am Coll Cardiol 2001; 37(3): 893-9. [DOI:10.1016/S0735-1097(00)01198-0]
18. Yaghoubi A, Mirinazhad M. Maternal and Neonatal Outcomes in Pregnant Patients with Cardiac Diseases Referred for Labour in Northwest Iran. J Pak Med Assoc 2013; 63(12): 1496-9. [PubMed]
19. Khairy P, Ouyang DW, Fernandes SM, et al. Pregnancy Outcomes in Women with Congenital Heart Disease. Circulation 2006; 113(4): 517-24. [DOI:10.1161/CIRCULATIONAHA.105.589655]
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
